Global Flow Cytometers
Global Flow Cytometers

Flow Cytometers Comprehensive Study by Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation, Hematology), Technology (Cell-based, Bead-based), End use (Hospitals and Clinics, Academia and Research Institutes, Pharmaceutical and Biotechnology Companies) Players and Region - Global Market Outlook to 2024

Flow Cytometers Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 240 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Flow cytometer detects the characteristics of population of cells or particle such as cell size, count, and cycle. The expression of surface and intracellular molecules is analyzed by this method. The flow cytometer provides specific information about the cells. Further, it uses the light to count the cells and profile it in a fluid mixture. Also, the series of sensors that are used to detect the light which is refracted from the cells. Then, the data acquired is compiled and used to build an image. The increasing usage of flow Cytometry for clinical laboratory is creating a demand for flow cytometer.

The market study is being classified, by Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation and Hematology) and major geographies with country level break-up.

Becton Dickinson (United States), Beckman Coulter (United States), Merck KGaA (Germany), Partec GMBH (Germany), Thermo Fisher (United States), Luminex Corp (United States), Miltenyi Biotec (Germany), Intellicyt Corp (United States), Sony (Japan) and Apogee Flow Systems (United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Advanced Analytical (United States), GE Healthcare (United States) and Union Biometrica (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Flow Cytometers market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Flow Cytometers market by Type, Application and Region.

On the basis of geography, the market of Flow Cytometers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Clinical Trials is Fueling the Market Growth
  • Increasing Need of Faster and Accurate Cancer Prognostic Tools

Market Trend
  • Adoption of Flow Cytometer for Research and Development
  • Increasing Awareness for Cell Based Assays

Restraints
  • High Costs of Equipment in Developing Economies

Opportunities
  • Government Initiatives for the Research and Development for Health Care
  • Rising Biotechnology Sector

Challenges
  • Lack of Awareness among the End Users


Market Leaders and their expansionary development strategies
In May 2019, Merck has acquired intermolecular Inc. which has a capability in rapid material screening.
In August 2019, Sysmex has launched PS10 Sample preparation system. It provides more efficient workflows and aids in standardizing flow cytometer testing.


Key Target Audience
Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Application
  • Oncology
  • Drug Discovery
  • Disease Diagnosis
  • Stem Cell Therapy
  • Organ Transplantation
  • Hematology
By Technology
  • Cell-based
  • Bead-based

By End use
  • Hospitals and Clinics
  • Academia and Research Institutes
  • Pharmaceutical and Biotechnology Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Clinical Trials is Fueling the Market Growth
      • 3.2.2. Increasing Need of Faster and Accurate Cancer Prognostic Tools
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness among the End Users
    • 3.4. Market Trends
      • 3.4.1. Adoption of Flow Cytometer for Research and Development
      • 3.4.2. Increasing Awareness for Cell Based Assays
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Flow Cytometers, by Application, Technology, End use and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Flow Cytometers (Value)
      • 5.2.1. Global Flow Cytometers by: Application (Value)
        • 5.2.1.1. Oncology
        • 5.2.1.2. Drug Discovery
        • 5.2.1.3. Disease Diagnosis
        • 5.2.1.4. Stem Cell Therapy
        • 5.2.1.5. Organ Transplantation
        • 5.2.1.6. Hematology
      • 5.2.2. Global Flow Cytometers by: Technology (Value)
        • 5.2.2.1. Cell-based
        • 5.2.2.2. Bead-based
      • 5.2.3. Global Flow Cytometers by: End use (Value)
        • 5.2.3.1. Hospitals and Clinics
        • 5.2.3.2. Academia and Research Institutes
        • 5.2.3.3. Pharmaceutical and Biotechnology Companies
      • 5.2.4. Global Flow Cytometers Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Flow Cytometers: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton Dickinson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Beckman Coulter (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck KGaA (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Partec GMBH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Luminex Corp (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Miltenyi Biotec (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Intellicyt Corp (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sony (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Apogee Flow Systems (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Flow Cytometers Sale, by Application, Technology, End use and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Flow Cytometers (Value)
      • 7.2.1. Global Flow Cytometers by: Application (Value)
        • 7.2.1.1. Oncology
        • 7.2.1.2. Drug Discovery
        • 7.2.1.3. Disease Diagnosis
        • 7.2.1.4. Stem Cell Therapy
        • 7.2.1.5. Organ Transplantation
        • 7.2.1.6. Hematology
      • 7.2.2. Global Flow Cytometers by: Technology (Value)
        • 7.2.2.1. Cell-based
        • 7.2.2.2. Bead-based
      • 7.2.3. Global Flow Cytometers by: End use (Value)
        • 7.2.3.1. Hospitals and Clinics
        • 7.2.3.2. Academia and Research Institutes
        • 7.2.3.3. Pharmaceutical and Biotechnology Companies
      • 7.2.4. Global Flow Cytometers Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Flow Cytometers: by Application(USD Million)
  • Table 2. Flow Cytometers Oncology , by Region USD Million (2013-2018)
  • Table 3. Flow Cytometers Drug Discovery , by Region USD Million (2013-2018)
  • Table 4. Flow Cytometers Disease Diagnosis , by Region USD Million (2013-2018)
  • Table 5. Flow Cytometers Stem Cell Therapy , by Region USD Million (2013-2018)
  • Table 6. Flow Cytometers Organ Transplantation , by Region USD Million (2013-2018)
  • Table 7. Flow Cytometers Hematology , by Region USD Million (2013-2018)
  • Table 8. Flow Cytometers: by Technology(USD Million)
  • Table 9. Flow Cytometers Cell-based , by Region USD Million (2013-2018)
  • Table 10. Flow Cytometers Bead-based , by Region USD Million (2013-2018)
  • Table 11. Flow Cytometers: by End use(USD Million)
  • Table 12. Flow Cytometers Hospitals and Clinics , by Region USD Million (2013-2018)
  • Table 13. Flow Cytometers Academia and Research Institutes , by Region USD Million (2013-2018)
  • Table 14. Flow Cytometers Pharmaceutical and Biotechnology Companies , by Region USD Million (2013-2018)
  • Table 15. South America Flow Cytometers, by Country USD Million (2013-2018)
  • Table 16. South America Flow Cytometers, by Application USD Million (2013-2018)
  • Table 17. South America Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 18. South America Flow Cytometers, by End use USD Million (2013-2018)
  • Table 19. Brazil Flow Cytometers, by Application USD Million (2013-2018)
  • Table 20. Brazil Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 21. Brazil Flow Cytometers, by End use USD Million (2013-2018)
  • Table 22. Argentina Flow Cytometers, by Application USD Million (2013-2018)
  • Table 23. Argentina Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 24. Argentina Flow Cytometers, by End use USD Million (2013-2018)
  • Table 25. Rest of South America Flow Cytometers, by Application USD Million (2013-2018)
  • Table 26. Rest of South America Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 27. Rest of South America Flow Cytometers, by End use USD Million (2013-2018)
  • Table 28. Asia Pacific Flow Cytometers, by Country USD Million (2013-2018)
  • Table 29. Asia Pacific Flow Cytometers, by Application USD Million (2013-2018)
  • Table 30. Asia Pacific Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 31. Asia Pacific Flow Cytometers, by End use USD Million (2013-2018)
  • Table 32. China Flow Cytometers, by Application USD Million (2013-2018)
  • Table 33. China Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 34. China Flow Cytometers, by End use USD Million (2013-2018)
  • Table 35. Japan Flow Cytometers, by Application USD Million (2013-2018)
  • Table 36. Japan Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 37. Japan Flow Cytometers, by End use USD Million (2013-2018)
  • Table 38. India Flow Cytometers, by Application USD Million (2013-2018)
  • Table 39. India Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 40. India Flow Cytometers, by End use USD Million (2013-2018)
  • Table 41. South Korea Flow Cytometers, by Application USD Million (2013-2018)
  • Table 42. South Korea Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 43. South Korea Flow Cytometers, by End use USD Million (2013-2018)
  • Table 44. Taiwan Flow Cytometers, by Application USD Million (2013-2018)
  • Table 45. Taiwan Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 46. Taiwan Flow Cytometers, by End use USD Million (2013-2018)
  • Table 47. Australia Flow Cytometers, by Application USD Million (2013-2018)
  • Table 48. Australia Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 49. Australia Flow Cytometers, by End use USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Flow Cytometers, by Application USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 52. Rest of Asia-Pacific Flow Cytometers, by End use USD Million (2013-2018)
  • Table 53. Europe Flow Cytometers, by Country USD Million (2013-2018)
  • Table 54. Europe Flow Cytometers, by Application USD Million (2013-2018)
  • Table 55. Europe Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 56. Europe Flow Cytometers, by End use USD Million (2013-2018)
  • Table 57. Germany Flow Cytometers, by Application USD Million (2013-2018)
  • Table 58. Germany Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 59. Germany Flow Cytometers, by End use USD Million (2013-2018)
  • Table 60. France Flow Cytometers, by Application USD Million (2013-2018)
  • Table 61. France Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 62. France Flow Cytometers, by End use USD Million (2013-2018)
  • Table 63. Italy Flow Cytometers, by Application USD Million (2013-2018)
  • Table 64. Italy Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 65. Italy Flow Cytometers, by End use USD Million (2013-2018)
  • Table 66. United Kingdom Flow Cytometers, by Application USD Million (2013-2018)
  • Table 67. United Kingdom Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 68. United Kingdom Flow Cytometers, by End use USD Million (2013-2018)
  • Table 69. Netherlands Flow Cytometers, by Application USD Million (2013-2018)
  • Table 70. Netherlands Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 71. Netherlands Flow Cytometers, by End use USD Million (2013-2018)
  • Table 72. Rest of Europe Flow Cytometers, by Application USD Million (2013-2018)
  • Table 73. Rest of Europe Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 74. Rest of Europe Flow Cytometers, by End use USD Million (2013-2018)
  • Table 75. MEA Flow Cytometers, by Country USD Million (2013-2018)
  • Table 76. MEA Flow Cytometers, by Application USD Million (2013-2018)
  • Table 77. MEA Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 78. MEA Flow Cytometers, by End use USD Million (2013-2018)
  • Table 79. Middle East Flow Cytometers, by Application USD Million (2013-2018)
  • Table 80. Middle East Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 81. Middle East Flow Cytometers, by End use USD Million (2013-2018)
  • Table 82. Africa Flow Cytometers, by Application USD Million (2013-2018)
  • Table 83. Africa Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 84. Africa Flow Cytometers, by End use USD Million (2013-2018)
  • Table 85. North America Flow Cytometers, by Country USD Million (2013-2018)
  • Table 86. North America Flow Cytometers, by Application USD Million (2013-2018)
  • Table 87. North America Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 88. North America Flow Cytometers, by End use USD Million (2013-2018)
  • Table 89. United States Flow Cytometers, by Application USD Million (2013-2018)
  • Table 90. United States Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 91. United States Flow Cytometers, by End use USD Million (2013-2018)
  • Table 92. Canada Flow Cytometers, by Application USD Million (2013-2018)
  • Table 93. Canada Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 94. Canada Flow Cytometers, by End use USD Million (2013-2018)
  • Table 95. Mexico Flow Cytometers, by Application USD Million (2013-2018)
  • Table 96. Mexico Flow Cytometers, by Technology USD Million (2013-2018)
  • Table 97. Mexico Flow Cytometers, by End use USD Million (2013-2018)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Flow Cytometers: by Application(USD Million)
  • Table 109. Flow Cytometers Oncology , by Region USD Million (2019-2024)
  • Table 110. Flow Cytometers Drug Discovery , by Region USD Million (2019-2024)
  • Table 111. Flow Cytometers Disease Diagnosis , by Region USD Million (2019-2024)
  • Table 112. Flow Cytometers Stem Cell Therapy , by Region USD Million (2019-2024)
  • Table 113. Flow Cytometers Organ Transplantation , by Region USD Million (2019-2024)
  • Table 114. Flow Cytometers Hematology , by Region USD Million (2019-2024)
  • Table 115. Flow Cytometers: by Technology(USD Million)
  • Table 116. Flow Cytometers Cell-based , by Region USD Million (2019-2024)
  • Table 117. Flow Cytometers Bead-based , by Region USD Million (2019-2024)
  • Table 118. Flow Cytometers: by End use(USD Million)
  • Table 119. Flow Cytometers Hospitals and Clinics , by Region USD Million (2019-2024)
  • Table 120. Flow Cytometers Academia and Research Institutes , by Region USD Million (2019-2024)
  • Table 121. Flow Cytometers Pharmaceutical and Biotechnology Companies , by Region USD Million (2019-2024)
  • Table 122. South America Flow Cytometers, by Country USD Million (2019-2024)
  • Table 123. South America Flow Cytometers, by Application USD Million (2019-2024)
  • Table 124. South America Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 125. South America Flow Cytometers, by End use USD Million (2019-2024)
  • Table 126. Brazil Flow Cytometers, by Application USD Million (2019-2024)
  • Table 127. Brazil Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 128. Brazil Flow Cytometers, by End use USD Million (2019-2024)
  • Table 129. Argentina Flow Cytometers, by Application USD Million (2019-2024)
  • Table 130. Argentina Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 131. Argentina Flow Cytometers, by End use USD Million (2019-2024)
  • Table 132. Rest of South America Flow Cytometers, by Application USD Million (2019-2024)
  • Table 133. Rest of South America Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 134. Rest of South America Flow Cytometers, by End use USD Million (2019-2024)
  • Table 135. Asia Pacific Flow Cytometers, by Country USD Million (2019-2024)
  • Table 136. Asia Pacific Flow Cytometers, by Application USD Million (2019-2024)
  • Table 137. Asia Pacific Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 138. Asia Pacific Flow Cytometers, by End use USD Million (2019-2024)
  • Table 139. China Flow Cytometers, by Application USD Million (2019-2024)
  • Table 140. China Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 141. China Flow Cytometers, by End use USD Million (2019-2024)
  • Table 142. Japan Flow Cytometers, by Application USD Million (2019-2024)
  • Table 143. Japan Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 144. Japan Flow Cytometers, by End use USD Million (2019-2024)
  • Table 145. India Flow Cytometers, by Application USD Million (2019-2024)
  • Table 146. India Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 147. India Flow Cytometers, by End use USD Million (2019-2024)
  • Table 148. South Korea Flow Cytometers, by Application USD Million (2019-2024)
  • Table 149. South Korea Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 150. South Korea Flow Cytometers, by End use USD Million (2019-2024)
  • Table 151. Taiwan Flow Cytometers, by Application USD Million (2019-2024)
  • Table 152. Taiwan Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 153. Taiwan Flow Cytometers, by End use USD Million (2019-2024)
  • Table 154. Australia Flow Cytometers, by Application USD Million (2019-2024)
  • Table 155. Australia Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 156. Australia Flow Cytometers, by End use USD Million (2019-2024)
  • Table 157. Rest of Asia-Pacific Flow Cytometers, by Application USD Million (2019-2024)
  • Table 158. Rest of Asia-Pacific Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 159. Rest of Asia-Pacific Flow Cytometers, by End use USD Million (2019-2024)
  • Table 160. Europe Flow Cytometers, by Country USD Million (2019-2024)
  • Table 161. Europe Flow Cytometers, by Application USD Million (2019-2024)
  • Table 162. Europe Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 163. Europe Flow Cytometers, by End use USD Million (2019-2024)
  • Table 164. Germany Flow Cytometers, by Application USD Million (2019-2024)
  • Table 165. Germany Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 166. Germany Flow Cytometers, by End use USD Million (2019-2024)
  • Table 167. France Flow Cytometers, by Application USD Million (2019-2024)
  • Table 168. France Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 169. France Flow Cytometers, by End use USD Million (2019-2024)
  • Table 170. Italy Flow Cytometers, by Application USD Million (2019-2024)
  • Table 171. Italy Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 172. Italy Flow Cytometers, by End use USD Million (2019-2024)
  • Table 173. United Kingdom Flow Cytometers, by Application USD Million (2019-2024)
  • Table 174. United Kingdom Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 175. United Kingdom Flow Cytometers, by End use USD Million (2019-2024)
  • Table 176. Netherlands Flow Cytometers, by Application USD Million (2019-2024)
  • Table 177. Netherlands Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 178. Netherlands Flow Cytometers, by End use USD Million (2019-2024)
  • Table 179. Rest of Europe Flow Cytometers, by Application USD Million (2019-2024)
  • Table 180. Rest of Europe Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 181. Rest of Europe Flow Cytometers, by End use USD Million (2019-2024)
  • Table 182. MEA Flow Cytometers, by Country USD Million (2019-2024)
  • Table 183. MEA Flow Cytometers, by Application USD Million (2019-2024)
  • Table 184. MEA Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 185. MEA Flow Cytometers, by End use USD Million (2019-2024)
  • Table 186. Middle East Flow Cytometers, by Application USD Million (2019-2024)
  • Table 187. Middle East Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 188. Middle East Flow Cytometers, by End use USD Million (2019-2024)
  • Table 189. Africa Flow Cytometers, by Application USD Million (2019-2024)
  • Table 190. Africa Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 191. Africa Flow Cytometers, by End use USD Million (2019-2024)
  • Table 192. North America Flow Cytometers, by Country USD Million (2019-2024)
  • Table 193. North America Flow Cytometers, by Application USD Million (2019-2024)
  • Table 194. North America Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 195. North America Flow Cytometers, by End use USD Million (2019-2024)
  • Table 196. United States Flow Cytometers, by Application USD Million (2019-2024)
  • Table 197. United States Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 198. United States Flow Cytometers, by End use USD Million (2019-2024)
  • Table 199. Canada Flow Cytometers, by Application USD Million (2019-2024)
  • Table 200. Canada Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 201. Canada Flow Cytometers, by End use USD Million (2019-2024)
  • Table 202. Mexico Flow Cytometers, by Application USD Million (2019-2024)
  • Table 203. Mexico Flow Cytometers, by Technology USD Million (2019-2024)
  • Table 204. Mexico Flow Cytometers, by End use USD Million (2019-2024)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Flow Cytometers: by Application USD Million (2013-2018)
  • Figure 5. Global Flow Cytometers: by Technology USD Million (2013-2018)
  • Figure 6. Global Flow Cytometers: by End use USD Million (2013-2018)
  • Figure 7. South America Flow Cytometers Share (%), by Country
  • Figure 8. Asia Pacific Flow Cytometers Share (%), by Country
  • Figure 9. Europe Flow Cytometers Share (%), by Country
  • Figure 10. MEA Flow Cytometers Share (%), by Country
  • Figure 11. North America Flow Cytometers Share (%), by Country
  • Figure 12. Global Flow Cytometers share by Players 2018 (%)
  • Figure 13. Global Flow Cytometers share by Players (Top 3) 2018(%)
  • Figure 14. Global Flow Cytometers share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 17. Becton Dickinson (United States) Revenue: by Geography 2018
  • Figure 18. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 19. Beckman Coulter (United States) Revenue: by Geography 2018
  • Figure 20. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Merck KGaA (Germany) Revenue: by Geography 2018
  • Figure 22. Partec GMBH (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Partec GMBH (Germany) Revenue: by Geography 2018
  • Figure 24. Thermo Fisher (United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fisher (United States) Revenue: by Geography 2018
  • Figure 26. Luminex Corp (United States) Revenue, Net Income and Gross profit
  • Figure 27. Luminex Corp (United States) Revenue: by Geography 2018
  • Figure 28. Miltenyi Biotec (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Miltenyi Biotec (Germany) Revenue: by Geography 2018
  • Figure 30. Intellicyt Corp (United States) Revenue, Net Income and Gross profit
  • Figure 31. Intellicyt Corp (United States) Revenue: by Geography 2018
  • Figure 32. Sony (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Sony (Japan) Revenue: by Geography 2018
  • Figure 34. Apogee Flow Systems (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Apogee Flow Systems (United Kingdom) Revenue: by Geography 2018
  • Figure 36. Global Flow Cytometers: by Application USD Million (2019-2024)
  • Figure 37. Global Flow Cytometers: by Technology USD Million (2019-2024)
  • Figure 38. Global Flow Cytometers: by End use USD Million (2019-2024)
  • Figure 39. South America Flow Cytometers Share (%), by Country
  • Figure 40. Asia Pacific Flow Cytometers Share (%), by Country
  • Figure 41. Europe Flow Cytometers Share (%), by Country
  • Figure 42. MEA Flow Cytometers Share (%), by Country
  • Figure 43. North America Flow Cytometers Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Becton Dickinson (United States)
  • Beckman Coulter (United States)
  • Merck KGaA (Germany)
  • Partec GMBH (Germany)
  • Thermo Fisher (United States)
  • Luminex Corp (United States)
  • Miltenyi Biotec (Germany)
  • Intellicyt Corp (United States)
  • Sony (Japan)
  • Apogee Flow Systems (United Kingdom)
Additional players considered in the study are as follows:
Advanced Analytical (United States) , GE Healthcare (United States) , Union Biometrica (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation